Interaction Guide · Research summary

Can I take Equisetum Arvense with Chlorthalidone?

Review Equisetum Arvense with Chlorthalidone: possible adverse effects and timing and monitoring, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Horsetail may affect fluid output, but no established spacing interval or universal chlorthalidone avoidance rule follows from the available human evidence. Review the exact preparation before combining two products intended to increase urination.

What this answer covers

Equisetum arvense aerial dry extract evidence; other horsetail species and blends are distinct.

Supplement or preparation
Equisetum arvense
Medication ingredient
chlorthalidone

The trial was short and did not use chlorthalidone

A study in 36 healthy men compared a standardized horsetail extract with placebo and hydrochlorothiazide in separate four-day periods. The extract increased negative fluid balance, but did not significantly change urinary sodium or potassium.

The clinical concern remains conditional

Chlorthalidone can cause dehydration, low pressure and kidney problems when diuresis is excessive. A horsetail fluid-balance effect makes product review sensible, but it does not show that the combination produces clinically important extra fluid loss.

Species and duration limit generalization

The study tested Equisetum arvense, not Equisetum hyemale, and only one extract over a few days. It cannot establish long-term safety in heart or kidney disease. A multi-herb water pill may also contain ingredients with different effects.

Spacing is not established protection

No source here demonstrates that a short gap between doses prevents a fluid-balance interaction. Tell the treating team about new urinary or weight-loss products, dizziness, faintness, marked thirst or reduced fluid intake. Chlorthalidone can itself cause excess fluid loss and kidney problems. Follow your existing fluid plan rather than increasing fluids or changing chlorthalidone on your own.

Evidence and practical considerations

Side effects & toxicity

Available preparation-specific guidance and indirect human studies do not establish this exact-pair adverse outcome; absence of proof is not proof of safety.

Exact scope
Equisetum arvense aerial dry extract evidence; other horsetail species and blends are distinct. with Oral chlorthalidone, exact RxCUI2409 IN. No automatic transfer from loop diuretics or another thiazide.
Medication form and route
oral medication; oral supplement

What remains uncertain

  • No universal risk rate or spacing interval; individual source limitations apply.

Factors that may matter: Preparation and plant part; Dose and duration; Kidney function; Fluid status; Other medicines; Calcium or potassium status.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People treated with oral chlorthalidone

Can cause fluid and electrolyte disturbances, including low potassium and sodium. Reduces urinary calcium excretion and can raise serum calcium; substantial elevation needs evaluation.

How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.

Exact oral product; not another thiazide or loop diuretic. Chlorothiazide sodium intravenous therapy is a separate route and salt. THALITONE has product-specific bioavailability and should not be assumed dose-for-dose identical to other formulations.

Source 2: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 36 healthy men.

Negative fluid balance increased versus placebo without significant urinary sodium or potassium change.

How this applies: Interpret only for the stated species, preparation, route and endpoints; exact chlorthalidone pair evidence is distinguished.

No chlorthalidone recipients. Short healthy-volunteer study does not establish long-term combination safety or severe hypotension; E. hyemale is distinct.

Research assessment: · Open full citations ↗

Timing & monitoring

No universal avoidance or protective spacing interval demonstrated. A narrower intake, preparation and clinical monitoring precaution may be appropriate.

Exact scope
Equisetum arvense aerial dry extract evidence; other horsetail species and blends are distinct. with Oral chlorthalidone, exact RxCUI2409 IN. No automatic transfer from loop diuretics or another thiazide.
Medication form and route
oral medication; oral supplement

What remains uncertain

  • No universal risk rate or spacing interval; individual source limitations apply.

Factors that may matter: Preparation and plant part; Dose and duration; Kidney function; Fluid status; Other medicines; Calcium or potassium status.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People treated with oral chlorthalidone

Can cause fluid and electrolyte disturbances, including low potassium and sodium. Reduces urinary calcium excretion and can raise serum calcium; substantial elevation needs evaluation.

How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.

Exact oral product; not another thiazide or loop diuretic. Chlorothiazide sodium intravenous therapy is a separate route and salt. THALITONE has product-specific bioavailability and should not be assumed dose-for-dose identical to other formulations.

Source 2: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 36 healthy men.

Negative fluid balance increased versus placebo without significant urinary sodium or potassium change.

How this applies: Interpret only for the stated species, preparation, route and endpoints; exact chlorthalidone pair evidence is distinguished.

No chlorthalidone recipients. Short healthy-volunteer study does not establish long-term combination safety or severe hypotension; E. hyemale is distinct.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact-pair article with separately verified drug label, original human evidence and explicit preparation and endpoint limitations.
Research summary published

Article revision: b21f8d1dbfa1be15

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.